Menu

Atrial fibrillation and heart failure

What is the programme and its aims?
The overall aim of the programme is to save lives by improving cardiovascular disease prevention and the management of cardiovascular risk in primary care.

The objectives of the programme are to:

  • Review evidence and best practice on effective cardiovascular disease prevention.
  • To create a compelling case for change through developing the scorecard for cardiovascular disease prevention and business case to demonstrate potential impact of improvements.
  • ‘Holding up a mirror’ to clinical commissioning groups and health and well-being boards on current service provision and performance in cardiovascular disease prevention by developing a scorecard on cardiovascular disease prevention data that can be benchmarked across East Midlands.
  • Review and develop options to support the spread of best practice including the development of new resources and/or signpost to existing resources to support implementation.
  • Reduce inequalities in cardiovascular disease prevention by working with clinical commissioning groups and general practices to implement quality improvement programmes
  • Provide clinical leadership and advice to clinical commissioning groups and health and well-being boards through the cardiovascular disease prevention task and finish group to support constituent organisations in improving cardiovascular disease prevention activities.

Why is the programme required?
3,322 people die prematurely of heart disease and stroke each year in the East Midlands, which equates to 14 people per day.

Cardiovascular disease was responsible for nearly 30% of deaths in 2011 and is the largest cause of disability. Cardiovascular disease is a major cause of premature death, with a quarter of deaths being before the age of 75. Cardiovascular disease means all the diseases of the heart and circulation including coronary heart disease (angina and heart attack), and stroke.

Despite significant improvements in cardiovascular mortality England still lags behind other countries in Europe and the ambition is for England to have the lowest rates of premature mortality from cancer, cardiovascular disease, respiratory and liver disease amongst European peers. If everyone had access to the best treatment that is already available, then following existing trends the NHS in England could avoid an extra 30,000 deaths per year by 2020.

Who are the partners?

  • clinical commissioning groups
  • acute trusts
  • local authorities
  • East Midlands Academic Health Science Network
  • Public Health England East Midlands
  • Third sector organisations – Atrial Fibrillation Association and British Heart Foundation
How are we making a difference?
  • Making a compelling case to improve the diagnosis and management of atrial fibrillation and heart failure and supporting clinical commissioning groups and practices to implement a quality improvement programmes
  • Providing resources including algorithm and computerised clinical template to support evidence based management in primary care
What’s next?
  • Update atrial fibrillation slide set (reduced version) and infographics to show improvement in atrial fibrillation diagnosis and anticoagulation and make case for continued improvement focus by clinical commissioning groups
  • Support adoption of atrial fibrillation clinical template and GraspAF to support improved diagnosis and management of atrial fibrillation
  • Hold community practice atrial fibrillation workshop in January 2016 to support clinical commissioning groups to develop robust plans to improve diagnosis and anticoagulation management
  • Update heart failure slide set (reduced version) and infographics to show improvement in heart failure management and make case for continued focus by clinical commissioning groups
  • Provide funding to clinical commissioning groups to support delivery of upskilling training for primary care staff in atrial fibrillation and heart failure management
  • Complete academic review of atrial fibrillation improvement programme
  • Produce infographic on cardiovascular disease to highlight to clinical commissioning groups opportunities for cardiovascular disease prevention and support clinical commissioning groups in developing strategic plans

Who to contact for further information?
This email address is being protected from spambots. You need JavaScript enabled to view it., Senior Quality Improvement Lead